查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1604586

抗毒素市場：按物種/類型 - 2025-2030 年全球預測

Antivenoms Market by Species (Scorpion, Snakes, Spiders), Type (Monovalent Antivenom, Polyvalent Antivenom) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年抗毒素市值為26.9億美元，預計2024年將達28.7億美元，複合年成長率為7.17%，預計2030年將達43.7億美元。

抗蛇毒血清市場對於治療蛇、蜘蛛、蠍子和其他有毒生物的毒咬傷和螫傷至關重要，並且在醫療保健、野生動物保護甚至軍事準備等領域也至關重要。在非洲、亞洲和拉丁美洲部分地區，與有毒動物頻繁接觸的地區迫切需要抗毒素，以拯救生命並預防嚴重併發症。應用範圍包括醫院、診所和現場工作，這對緊急醫療團隊來說至關重要。最終用途包括醫療機構、研究機構和實施公共衛生舉措的政府。抗蛇毒血清市場的關鍵成長要素包括全球毒液咬傷發生率上升、醫療基礎設施投資增加以及人們對抗蛇毒血清治療的可用性和需求的認知不斷提高。基因組學和生物技術的技術進步也在擴大產品創新，並為開發更安全、更有效的抗蛇毒血清提供了機會。然而，市場面臨生產成本高、監管要求嚴格、動物毒素產量波動導致供需失衡等挑戰。此外，某些地區的認知度低也限制了市場的成長。公司可以透過投資重組技術和探索單株抗體和合成胜肽等多樣化平台來進行創新。頻譜抗蛇毒血清的研究是降低生產成本和提高功效的一個有前景的領域。與高風險地區的醫療保健提供者建立夥伴關係可以加強您的分銷網路並提高市場滲透率。該市場本質上是利基市場，但隨著研究對毒液和抗毒素製劑的性質產生新的見解，該市場不斷擴大。重點還應放在提高當地生產能力以應對出口限制並減少對特定毒液來源的依賴，最終降低成本並提高可用性。隨著市場的發展，利用這些成長路徑將有助於確保業務擴張並鞏固我們作為挽救生命的醫療保健解決方案領導者的地位。

主要市場統計
基準年[2023] 26.9億美元
預計年份 [2024] 28.7億美元
預測年份 [2030] 43.7億美元
複合年成長率（%） 7.17%

市場動態：揭示快速發展的抗毒素市場的關鍵市場洞察

供需的動態交互作用正在改變抗蛇毒血清市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 蛇咬傷案例增加
    • 提高對可用作急救治療的抗蛇毒血清的認知
    • 加大農村地區醫療衛生基礎建設力度
  • 市場限制因素
    • 抗蛇毒血清生產成本高
  • 市場機會
    • 抗毒素生產技術進步
    • 改善各國的抗毒素分銷網路
  • 市場挑戰
    • 缺乏抗蛇毒血清生產的監管標準

波特的五力：駕馭抗毒素市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解抗毒素市場的外部影響

外部宏觀環境因素在塑造抗毒素市場的表現動態中發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解抗毒素市場的競爭格局

對抗毒素市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣抗毒素市場供應商的績效評估

FPNV定位矩陣是評估抗毒素市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製抗毒素市場的成功之路

抗毒素市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 蛇咬傷事件增加
      • 提高對可用於緊急醫療護理的抗毒素的認知
      • 改善當地醫療基礎設施的進展
    • 抑制因素
      • 抗毒素生產成本高
    • 機會
      • 抗毒素生產技術進步
      • 改善各國的抗毒素分銷網路
    • 任務
      • 缺乏抗蛇毒血清生產的監管標準
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 抗毒素市場：類型

  • 蠍
  • 蛇
  • 蜘蛛

第7章抗毒素市場：依類型

  • 單價抗毒素
  • 多效價抗毒素

第8章美洲抗毒素市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太抗毒素市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲抗毒素市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Amsaal LLC
  • BB-NCIPD Ltd.
  • Bharat Serums and Vaccines Limited（BSV）
  • Boehringer Ingelheim International GmbH.
  • BTG International Inc.
  • Creative BioMart
  • CSL
  • Haffkine Bio-Pharmaceutical Corporation Ltd.
  • Incepta Pharma
  • Inosan Biopharma
  • Institute of Vaccines and Medical Biologicals
  • Instituto Clodomiro Picado
  • KM Biologics
  • Laboratorios Silanes, SA de CV
  • Lexicare Pharma Pvt. Ltd.
  • Medtoxin Venom Laboratories, LLC
  • Merck & Co., Inc.
  • MicroPharm
  • Padula Serums Pty Ltd.
  • Pfizer Inc.
  • Rare Disease Therapeutics, Inc.
  • Serum Institute of India Pvt. Ltd.
  • Shanghai Serum Bio-technology Co., Ltd.
  • VINS Bioproducts Ltd.
Product Code: MRR-C002B1C99489

The Antivenoms Market was valued at USD 2.69 billion in 2023, expected to reach USD 2.87 billion in 2024, and is projected to grow at a CAGR of 7.17%, to USD 4.37 billion by 2030.

The antivenoms market is crucial for treating venomous bites and stings from snakes, spiders, scorpions, and other venomous creatures, making it vital for areas like healthcare, wildlife conservation, and even military preparedness. Antivenoms are urgently necessary in regions with high incidences of venomous animal encounters, such as parts of Africa, Asia, and Latin America, where they save lives and prevent serious complications. Application areas include hospitals, clinics, and field operations, and they are essential for emergency medical teams. The scope of end-use extends to healthcare facilities, research institutions, and governments implementing public health initiatives. Key growth factors in the antivenom market include the rising incidence of venomous bites worldwide, growing investments in healthcare infrastructure, and increasing awareness about the availability and necessity of antivenom treatments. Technological advancements in genomics and biotechnology are also expanding product innovation, offering opportunities to develop safer, more effective antivenoms. However, the market faces challenges such as high production costs, stringent regulatory requirements, and supply-demand imbalances exacerbated by fluctuating animal venom yields. Limited awareness in certain regions also constrains market growth. Organizations can innovate by investing in recombinant technology and exploring diversified platforms like monoclonal antibodies or synthetic peptide antivenoms. Research into broad-spectrum antivenoms is a promising area for reducing manufacturing costs and improving efficacy. Establishing partnerships with local healthcare providers in high-risk regions can enhance distribution networks and market penetration. The nature of the market is niche but expanding, as research provides new insights into venom properties and antivenom formulations. Emphasis should also be on boosting local production capabilities to combat export restrictions and reducing dependency on specific venom sources, ultimately driving down costs and improving accessibility. As the market evolves, tapping into these growth avenues can secure business expansion and solidify a company's standing as a leader in lifesaving healthcare solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 2.69 billion
Estimated Year [2024] USD 2.87 billion
Forecast Year [2030] USD 4.37 billion
CAGR (%) 7.17%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antivenoms Market

The Antivenoms Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of snake bites
    • Rising awareness of antivenoms available as first-aid
    • Increasing improvements in healthcare infrastructure in rural areas
  • Market Restraints
    • High production cost of antivenoms
  • Market Opportunities
    • Technical advancements in antivenoms production
    • Improvement in distribution networks of antivenoms in countries
  • Market Challenges
    • Lack of regulatory norms for antivenom manufacturing

Porter's Five Forces: A Strategic Tool for Navigating the Antivenoms Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antivenoms Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antivenoms Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antivenoms Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antivenoms Market

A detailed market share analysis in the Antivenoms Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antivenoms Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antivenoms Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antivenoms Market

A strategic analysis of the Antivenoms Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antivenoms Market, highlighting leading vendors and their innovative profiles. These include Amsaal LLC, BB - NCIPD Ltd., Bharat Serums and Vaccines Limited (BSV), Boehringer Ingelheim International GmbH., BTG International Inc., Creative BioMart, CSL, Haffkine Bio-Pharmaceutical Corporation Ltd., Incepta Pharma, Inosan Biopharma, Institute of Vaccines and Medical Biologicals, Instituto Clodomiro Picado, KM Biologics, Laboratorios Silanes, S.A. de C.V, Lexicare Pharma Pvt. Ltd., Medtoxin Venom Laboratories, LLC, Merck & Co., Inc., MicroPharm, Padula Serums Pty Ltd., Pfizer Inc., Rare Disease Therapeutics, Inc., Serum Institute of India Pvt. Ltd., Shanghai Serum Bio-technology Co., Ltd., and VINS Bioproducts Ltd..

Market Segmentation & Coverage

This research report categorizes the Antivenoms Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Species, market is studied across Scorpion, Snakes, and Spiders.
  • Based on Type, market is studied across Monovalent Antivenom and Polyvalent Antivenom.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of snake bites
      • 5.1.1.2. Rising awareness of antivenoms available as first-aid
      • 5.1.1.3. Increasing improvements in healthcare infrastructure in rural areas
    • 5.1.2. Restraints
      • 5.1.2.1. High production cost of antivenoms
    • 5.1.3. Opportunities
      • 5.1.3.1. Technical advancements in antivenoms production
      • 5.1.3.2. Improvement in distribution networks of antivenoms in countries
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of regulatory norms for antivenom manufacturing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Antivenoms Market, by Species

  • 6.1. Introduction
  • 6.2. Scorpion
  • 6.3. Snakes
  • 6.4. Spiders

7. Antivenoms Market, by Type

  • 7.1. Introduction
  • 7.2. Monovalent Antivenom
  • 7.3. Polyvalent Antivenom

8. Americas Antivenoms Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Antivenoms Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Antivenoms Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amsaal LLC
  • 2. BB - NCIPD Ltd.
  • 3. Bharat Serums and Vaccines Limited (BSV)
  • 4. Boehringer Ingelheim International GmbH.
  • 5. BTG International Inc.
  • 6. Creative BioMart
  • 7. CSL
  • 8. Haffkine Bio-Pharmaceutical Corporation Ltd.
  • 9. Incepta Pharma
  • 10. Inosan Biopharma
  • 11. Institute of Vaccines and Medical Biologicals
  • 12. Instituto Clodomiro Picado
  • 13. KM Biologics
  • 14. Laboratorios Silanes, S.A. de C.V
  • 15. Lexicare Pharma Pvt. Ltd.
  • 16. Medtoxin Venom Laboratories, LLC
  • 17. Merck & Co., Inc.
  • 18. MicroPharm
  • 19. Padula Serums Pty Ltd.
  • 20. Pfizer Inc.
  • 21. Rare Disease Therapeutics, Inc.
  • 22. Serum Institute of India Pvt. Ltd.
  • 23. Shanghai Serum Bio-technology Co., Ltd.
  • 24. VINS Bioproducts Ltd.

LIST OF FIGURES

  • FIGURE 1. ANTIVENOMS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIVENOMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTIVENOMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIVENOMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIVENOMS MARKET SIZE, BY SPECIES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTIVENOMS MARKET SIZE, BY SPECIES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIVENOMS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTIVENOMS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ANTIVENOMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ANTIVENOMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTIVENOMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTIVENOMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIVENOMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTIVENOMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIVENOMS MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTIVENOMS MARKET SIZE, BY SCORPION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTIVENOMS MARKET SIZE, BY SNAKES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTIVENOMS MARKET SIZE, BY SPIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTIVENOMS MARKET SIZE, BY MONOVALENT ANTIVENOM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTIVENOMS MARKET SIZE, BY POLYVALENT ANTIVENOM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ANTIVENOMS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. ANTIVENOMS MARKET, FPNV POSITIONING MATRIX, 2023